This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
The International Kidney Cancer Symposium (IKCS) 2022: North America
Viewing 21-40 of 47 articles
IKCS 2022: Collecting Duct, Sarcomatoid, and Rhabdoid Subtypes of Renal Cell Carcinoma
IKCS 2022: Biomarkers of Disease Burden and Treatment Response in Renal Medullary Carcinoma
IKCS 2022: Circulating Biomarkers in Renal Cell Carcinoma
IKCS 2022: Keynote Lecture: The Trajectory of Immunotherapy in Renal Cell Carcinoma
IKCS 2022: Translocation Type Subtypes of Renal Cell Carcinoma
IKCS 2022: Spatial Molecular Imaging to Profile the Epithelial to Mesenchymal Transition and Immune Crosstalk in Sarcomatoid Renal Cell Carcinoma
IKCS 2022: Multidisciplinary Management of Renal Medullary Cancer
IKCS 2022: Association Between Depth of Response (DepOR) and Clinical Outcomes: Exploratory Analysis in Patients with Previously Untreated Advanced Renal Cell Carcinoma (aRCC) in CheckMate 9ER
IKCS 2022: The Patient Perspective on Side-effects and Care
IKCS 2022: The Professional State of Renal Cell Carcinoma
IKCS 2022: Outcomes of Active Surveillance for Young and Healthy Patients with Small Renal Masses
IKCS 2022: Long-Term PFS from TIVO-3: Tivozanib (TIVO) vs Sorafenib (SOR) in Relapsed/refractory (R/R) Advanced RCC
IKCS 2022: APART – a Phase 2 Trial of Axitinib, Palbociclib and Avelumab as Advanced Clear Cell Renal Cell Carcinoma (ccRCC) Therapy
IKCS 2022: Session 2 Debate: Adjuvant or Not?
IKCS 2022: Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
IKCS 2022: Session 1 Debate: Surveillance vs. Intervention
IKCS 2022: A Phase II Study of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Renal Cell Carcinoma (mRCC) That Progressed on a PD-1/PD-L1 Checkpoint Inhibitor (LenCabo)
IKCS 2022: A Randomized Trial of Radium-223 (Ra-223) Dichloride and Cabozantinib in Patients (Pts) with Advanced Renal Cell Carcinoma (RCC) with Bone Metastases (RADICAL / Alliance A031801)
IKCS 2022: Phase 2 Trial for Sequential Treatment after Cabozantinib Progression in Metastatic Renal Cell Carcinoma (Seq-Cabo)
IKCS 2022: Characterization of Patients Undergoing Consolidative Nephrectomy after Immunotherapy
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
